The catastrophic Ebola epidemic that began in 2014 placed a significant burden on Sierra Leone’s already weak pharmaceutical supply system. The country’s public-sector storage, handling, distribution, and waste disposal practices were in dire need of improvement. The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program received two years of funding from USAID to provide technical assistance to rebuild and strengthen pharmaceutical supply chain management and improve rational medicine use in Sierra Leone.
SIAPS has supported systems strengthening activities in the following areas:
Governance and leadership of central and district health management teams
The project assisted in developing the capacity of the Directorate of Drugs and Medical Supplies in leadership, management, and governance by revising its organization structure and terms of reference. SIAPS also participated in the development of the Antimicrobial Resistance National Strategic Plan and held leadership and management training for pharmacists from around the country, teaching them strategies to uncover and address service gaps and infrastructure challenges.
Supply chain management to ensure product availability and rational medicine use
SIAPS helped the country institute a continuous results monitoring and support system (CRMS) to assess baseline challenges in pharmaceutical management and regularly track and support improvements in key areas. The CRMS uses a series of indicators to track and monitor factors that influence medicine availability and disease case management.
Information systems to improve the use of information for decision making
SIAPS supported the implementation of its electronic data management tools—Quantimed, Pipeline, and QuanTB—and supported the National AIDS Secretariat in establishing the Sierra Leone Pharmaceutical Dashboard, a web-based early warning system that provides real-time visual data on patient and product information. The program also introduced a revised treatment/pharmacy register that captures data on tracer and key pharmaceuticals, including 13 essential products and selected Ebola-related commodities. It is a key source of actual consumption data to monitor inventory and promote the rational use of pharmaceutical products.
|Project Name||Health Systems||Health Areas||Date|
|Systems for Improved Access to Pharmaceuticals and Services Program||Pharmaceutical Management, Financing Health Services, Global Health Security||Malaria, Tuberculosis, HIV & AIDS, Maternal, Newborn, & Child Health, Family Planning & Reproductive Health, Women, Children, and Adolescents' Health||2011 - 2018|
African Strategies for Health
|Leadership, Management & Governance, Financing Health Services||Malaria, Tuberculosis, Maternal, Newborn, & Child Health, HIV & AIDS||2011 - 2016|
Leadership, Management and Governance Project
|Leadership, Management & Governance||Family Planning & Reproductive Health, HIV & AIDS, Tuberculosis||2012 - 2017|